338 related articles for article (PubMed ID: 26068001)
21. A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).
Kim YC; Yang JY; Yoon JS; Jo SJ; Ahn HH; Song KH; Lee DY; Chung KY; Won YH; Kim IH
Br J Dermatol; 2018 Oct; 179(4):836-843. PubMed ID: 29355904
[TBL] [Abstract][Full Text] [Related]
22. Relative efficacy of 5-fluorouracil compared with other treatments among patients with actinic keratosis: A network meta-analysis.
Wu Y; Tang N; Cai L; Li Q
Dermatol Ther; 2019 May; 32(3):e12822. PubMed ID: 30638294
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.
Jim On SC; Hashim PW; Nia JK; Lebwohl MG
J Drugs Dermatol; 2017 May; 16(5):432-436. PubMed ID: 28628678
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
[TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
[TBL] [Abstract][Full Text] [Related]
26. Monitoring Ingenol Mebutate Gel Treatment of Actinic Keratoses by Reflectance Confocal Microscopy.
López Estebaranz JL; Pampín Franco A; Gamo Villegas R; Floristán U
Acta Derm Venereol; 2017 May; 97(5):646-648. PubMed ID: 28093603
[No Abstract] [Full Text] [Related]
27. Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Jansen MHE; Kessels JPHM; Nelemans PJ; Kouloubis N; Arits AHMM; van Pelt HPA; Quaedvlieg PJF; Essers BAB; Steijlen PM; Kelleners-Smeets NWJ; Mosterd K
N Engl J Med; 2019 Mar; 380(10):935-946. PubMed ID: 30855743
[TBL] [Abstract][Full Text] [Related]
28. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
[TBL] [Abstract][Full Text] [Related]
29. Ingenol mebutate: a new option for actinic keratosis treatment.
Gras J
Drugs Today (Barc); 2013 Jan; 49(1):15-22. PubMed ID: 23362492
[TBL] [Abstract][Full Text] [Related]
30. Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.
Herranz P; Morton C; Dirschka T; Azeredo RR; Roldán-Marín R
J Cutan Med Surg; 2016 Nov; 20(6):555-561. PubMed ID: 27443886
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
[TBL] [Abstract][Full Text] [Related]
32. Erosive pustular dermatosis of the scalp following topical ingenol mebutate for actinic keratoses.
Vaccaro M; Borgia F; Gasco L; Cannavò SP
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28685901
[No Abstract] [Full Text] [Related]
33. Combination Therapies: Laser-Assisted Delivery of 5-Fluorouracil.
Petersen Vitello Kalil CL; Herman Reinehr CP; de Mattos Milman L; Bakos RM
Dermatol Surg; 2019 Mar; 45(3):485-487. PubMed ID: 29933300
[No Abstract] [Full Text] [Related]
34. Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.
Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Goncalves J; Larsson T; Skov T; Swanson N
J Drugs Dermatol; 2014 Feb; 13(2):154-60. PubMed ID: 24509965
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study.
Garbe C; Basset-Seguin N; Poulin Y; Larsson T; Østerdal ML; Venkata R; Lear JT
Br J Dermatol; 2016 Mar; 174(3):505-13. PubMed ID: 26471889
[TBL] [Abstract][Full Text] [Related]
36. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives.
Gameiro L; Tovo LFR; Sanches Júnior JA; Aprahamian I
An Bras Dermatol; 2019 Jul; 94(3):313-319. PubMed ID: 31365660
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.
Nieves D; Puig-Peiró R; Ferrándiz C; Plazas MJ; Brosa M
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):539-43. PubMed ID: 25495775
[TBL] [Abstract][Full Text] [Related]
38. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
Berman B
Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
[TBL] [Abstract][Full Text] [Related]
39. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
Nguyen HP; Rivers JK
Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
[TBL] [Abstract][Full Text] [Related]
40. Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis.
Nisticò S; Del Duca E; Torchia V; Gliozzi M; Bottoni U; Muscoli C
Int J Immunopathol Pharmacol; 2018; 32():2058738418757925. PubMed ID: 29442526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
